Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells.

导出原文传递

翻译打印收藏纠错

第一作者： Masato,Hioki

第一单位： Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan.

作者： Masato,Hioki ^[1] ; Takuya,Shimada ^[2] ; Tian,Yuan ^[3] ; Takeo,Nakanishi ^[3] ; Hidehiro,Tajima ^[4] ; Maiko,Yamazaki ^[5] ; Rina,Yokono ^[3] ; Makiko,Takabayashi ^[3] ; Kazuki,Sawamoto ^[3] ; Gaku,Akashita ^[3] ; Ken-Ichi,Miyamoto ^[3] ; Tetsuo,Ohta ^[3] ; Ikumi,Tamai ^[5] ; Tsutomu,Shimada ^[4] ; Yoshimichi,Sai ^[1]

作者单位： Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan. ^[1] Department of Pharmacy, Local Independent Administrative Institution Mie Prefectural General Medical Center, 5450-132 Hinaga, Yokkaichi City, Mie, 510-8561, Japan. ^[2] Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan. ^[3] Faculty of Pharmaceutical Sciences, Department of Membrane Transport and Biopharmaceutics, Kanazawa University, Kakuma-machi, Kanazawa, 920-1192, Japan. ^[4] Department of Gastroenterological Surgery, Division of Cancer Medicine, Graduate School of Medical Sciences, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan. ^[5]

关键词 equilibrative nucleoside transporters gemcitabine pancreatic cancer cell uptake kinetics